Healthcare Industry News: Vertiflex
News Release - October 14, 2008
VertiFlex(R) Progresses on the ISISS IDE Trial Through the Addition of Catherine Kusnick, MD as Vice President, Medical and Clinical AffairsSAN CLEMENTE, Calif.--(HSMN NewsFeed)--Vertiflex®, Inc, a privately held spinal medical device company specializing in the development of percutaneous, minimally invasive, and motion preservation technologies for disorders of the spine, announced today the recent addition of Catherine Kusnick, M.D. as Vice President, Medical and Clinical Affairs and the continued progress of the ISISS clinical trial investigating the Superion™ Interspinous Spacer for the treatment of spinal stenosis.
Dr. Kusnick is a seasoned physician executive with 25 years of clinical research and practice experience, disease management expertise and strategic development of new products on a global basis. She brings extensive experience in all facets of product development for Class II and III devices leading to PMA submission and publications for medical conferences and peer-reviewed journals. She has built, restructured and managed clinical departments at three medical device start-up companies in multiple therapeutic areas including spine. Dr. Kusnick completed her medical training and pre-doctoral education at University of California at Irvine and San Diego, Stanford University and Wellesley College. She is a Diplomat of the American Board of Radiology with sub-specialization in high tech diagnostic methods and percutaneous treatment. Prior to joining Vertiflex, Dr. Kusnick headed the Clinical Affairs departments at: Interventional Spine, 3F Therapeutics, and SenoRx.
“I am pleased with the current progress of the ISISS trial to date and with the ongoing addition of sites and continued patient enrollment. Based on her wealth of experience and credentials, Dr. Kusnick will be instrumental in achieving our clinical milestones,” remarked Earl R. Fender, President and CEO.
Founded in 2005, Vertiflex®, Inc. is a privately held venture-backed medical device company headquartered in San Clemente, California and operating both in the U.S. and globally. The company is dedicated to the development and advancement of percutaneous, minimally invasive, and motion preservation technologies for disorders of the spine. Vertiflex® is committed to delivering advanced products that transform patient outcomes, and offers a full compliment of solutions. These include the Silverbolt™ Percutaneous Posterior Fixation System, which allows for multi-level percutaneous, minimally invasive or mini-open screw fixation, the Octane™ Product Family of Interbody Implants and the Oracle® Expandable Retractor. Vertiflex's product line also includes the Dynabolt™ Dynamic Stabilization System, a pedicle screw-based motion system delivered percutaneously through the Silverbolt™ System, and the Superion™ Interspinous Spacer. These motion preservation product offerings allow for an array of solutions for multiple indications. The Superion™ Interspinous Spacer is currently under clinical investigation in the U.S.
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.